Endoglin in human liver disease and murine models of liver fibrosis : a protective factor against liver fibrosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1111/liv.13595
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2017
- Creator
-
Alsamman, Muhammad
Sterzer, Viktor
Meurer, Steffen K.
Sahin, Hacer
Schäper, Ute
Kuscuoglu, Deniz
Strnad, Pavel
Weiskirchen, Ralf
Trautwein, Christian
Scholten, David
- DOI
-
10.18154/RWTH-CONV-219947
- URN
-
urn:nbn:de:101:1-2019082607451834186138
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alsamman, Muhammad
- Sterzer, Viktor
- Meurer, Steffen K.
- Sahin, Hacer
- Schäper, Ute
- Kuscuoglu, Deniz
- Strnad, Pavel
- Weiskirchen, Ralf
- Trautwein, Christian
- Scholten, David
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2017
Other Objects (12)
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Mechanisms of liver fibrosis resolution
Cellular Mechanisms of Liver Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Magnetic-Assisted Treatment of Liver Fibrosis
Magnetic-Assisted Treatment of Liver Fibrosis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation